Asia-Pacific Western Blotting Market Report - Segmented By Product, Application, End-User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends and Growth Forecast (2024 to 2029)

Updated On: January, 2024
ID: 4909
Pages: 145

APAC Western blotting market Size (2024 to 2029)

The size of the Asia Pacific Western blotting market is valued at USD 128.89 million in 2024. This value is expected to reach USD 174.12 million by 2029, at a 6.2% CAGR during the forecast period. Asia Pacific is expected to grow with the highest CAGR during the forecast period. It can be because of expanding government and its interests for the biomedical and biotechnology industry in China, bio clusters in China and India, and other major regions in Asia pacific. Government activities are upheld by support in Japan. Indian drug industries are also concentrating more on manufacturing testing kits for various assays and techniques like western blotting. It is encouraged by multiple governmental, non-governmental, and public funds to the healthcare sector. 

Western blotting is an analytical technique used widely in molecular biology and immune genetics to detect and identify specific proteins in a tissue extract. The western blotting technique's beneficial factors include qualitative detection of single proteins in biochemistry, quantification of complex and mixture of proteins. Western blotting is also used as confirmatory tests in HIV disease testing and detection. World Anti-Doping Agency (WADA) also includes the western blotting test as a significant test. Blood doping is a misuse of substances that increase erythropoietin's total mass in red blood cells, thereby increasing oxygen levels. Most commonly seen in athletes to increase stamina and performance. In such cases, a western blot test is used to detect any drug substances.

Increased research and developmental activities share maximum growth for this market across the Asia Pacific region. Growth in industries like genomics, proteomics also increases this market. Other factors such as government implementations on creating awareness, research programs, collaborations on providing knowledge, rise in the adaption of personalized health checkups and medicines, rise in prevalence of chronic infections, and diseases increase demand for this market in the Asia Pacific region. 

Besides growth contributing factors, few market restraints held back market growth and restricted its activities. High-end costs associated with the lab devices and testing kits, low investors, and least interest in developing this market are market restraints for this market. The accuracy of the testing process is sometimes not appropriately achieved, creating problems in identifying and detecting the underlying cause. It is also difficult to import and export the testing kits to be handled very carefully. A lot of skilled staff and professional lab workers are needed for the testing process. The reagents used for the testing process and even for manufacturing these kits are available in small amounts. 

This research report on the APAC Western blotting market has been segmented and sub-segmented into the following categories:

  • By Product: Instruments, Consumables
  • By Application: Biomedical & Biochemical Research, Disease Diagnostics
  • By End User: Academic & Research Institutes, Pharmaceutical & Biotechnology Companies
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

In the coming years, the Asia-Pacific region is expected to witness the highest growth in the western blotting market, emphasizing India, China, and Japan. It can be attributed to increasing government interest in the biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, improving diagnosis and related financing in Australia, and increasing herpes simplex prevalence virus (HSV) in southeast Asia.

The Top companies leading in the APAC Western blotting market profiled in the report are  Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample